These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8029476)

  • 41. [A quantitative determination of inducibility by 14 membered ring macrolide antibiotics in inducible resistant Staphylococcus aureus to macrolide-lincosamide-streptogramin B antibiotics].
    Kobayashi H; Endou K; Nakajima Y
    Yakugaku Zasshi; 1994 Dec; 114(12):1015-20. PubMed ID: 7869234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
    Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
    Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
    Champney WS; Tober CL
    Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibiotics 1992: mechanism of resistance and its clinical relevance].
    Desgrandchamps D
    Schweiz Med Wochenschr; 1992 Feb; 122(8):247-56. PubMed ID: 1542777
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity.
    Werner G; Hagenmaier H; Drautz H; Baumgartner A; Zähner H
    J Antibiot (Tokyo); 1984 Feb; 37(2):110-7. PubMed ID: 6423597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
    Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
    Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azithromycin: a new 15-membered macrolide.
    Treadway G
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():70-6. PubMed ID: 11296412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and structural elucidation of new 18-membered macrolide antibiotics, viranamycins A and B.
    Hayakawa Y; Takaku K; Furihata K; Nagai K; Seto H
    J Antibiot (Tokyo); 1991 Dec; 44(12):1294-9. PubMed ID: 1778781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of macrolide antibiotics against mucoid Pseudomonas aeruginosa].
    Yokoiyama S
    Kansenshogaku Zasshi; 1990 Nov; 64(11):1439-46. PubMed ID: 2126800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketolides lack inducibility properties of MLS(B) resistance phenotype.
    Bonnefoy A; Girard AM; Agouridas C; Chantot JF
    J Antimicrob Chemother; 1997 Jul; 40(1):85-90. PubMed ID: 9249208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RS-22A, B and C: new macrolide antibiotics from Streptomyces violaceusniger. I. Taxonomy, fermentation, isolation and biological activities.
    Ubukata M; Shiraishi N; Kobinata K; Kudo T; Yamaguchi I; Osada H; Shen YC; Isono K
    J Antibiot (Tokyo); 1995 Apr; 48(4):289-92. PubMed ID: 7775264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural studies of new macrolide antibiotics, shurimycins A and B.
    Kumazawa S; Asami Y; Awane K; Ohtani H; Fukuchi C; Mikawa T; Hayase T
    J Antibiot (Tokyo); 1994 Jun; 47(6):688-96. PubMed ID: 8040074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antimicrobial activity of macrolides against clinical isolates].
    Hoshino K; Iwai Y; Nakamura S; Seto I; Yamaguchi K
    Jpn J Antibiot; 1998 Apr; 51(4):249-71. PubMed ID: 9644599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural consideration of macrolide antibiotics in relation to the ribosomal interaction and drug design.
    Takashima H
    Curr Top Med Chem; 2003; 3(9):991-9. PubMed ID: 12678833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?
    Baquero F
    J Chemother; 1999 Feb; 11 Suppl 1():35-43. PubMed ID: 10207772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new insight into solid-state conformation of macrolide antibiotics.
    Miroshnyk I; Mirza S; Zorky PM; Heinämäki J; Yli-Kauhaluoma J; Yliruusi J
    Bioorg Med Chem; 2008 Jan; 16(1):232-9. PubMed ID: 17936632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation and characterization of concanamycins A, B and C.
    Kinashi H; Someno K; Sakaguchi K
    J Antibiot (Tokyo); 1984 Nov; 37(11):1333-43. PubMed ID: 6511660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
    Kondoh K; Hashiba M
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Jan; 101(1):25-36. PubMed ID: 9493436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Appearance in Japan of highly macrolide-resistant Escherichia coli producing macrolide 2'-phosphotransferase II.
    Taniguchi K; Nakamura A; Tsurubuchi K; Ishii A; O'Hara K; Sawai T
    Microbios; 1999; 97(388):137-44. PubMed ID: 10413869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
    Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
    Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.